Bone Marrow Transplant in Thailand Your guide to cost, top specialists & hospitals

Our partner hospitals operate dedicated bone marrow transplant units within their haematology departments. Leading JCI-accredited hospitals in Bangkok run transplant programmes with HEPA-filtered isolation wards, on-site stem cell processing laboratories, blood banking services, and intensive care units equipped for transplant complications.

Our partner haematologists are board-certified with fellowship training in transplant medicine. Many completed advanced training at international transplant centres and bring that experience to managing the complex clinical decisions that arise during conditioning, engraftment, and long-term follow-up.

HEPA-filtered isolation rooms, on-site blood banking, and 24-hour haematology coverage are non-negotiable. Ask about annual transplant volume; centres performing a higher number of procedures each year tend to manage complications more effectively. Confirm the centre has experience with your specific transplant type.

Engraftment, when donor cells begin producing new blood cells, typically occurs within two to three weeks¹. Many patients with acute leukaemia achieve long-term remission after allogeneic transplant, though the likelihood varies widely with disease risk: good-risk leukaemia in first remission does considerably better than relapsed, refractory, or high-risk cytogenetic disease. Autologous transplant for myeloma extends progression-free survival by several years. Outcomes improve steadily with advances in conditioning, GVHD prevention, and supportive care.

Your haematologist discusses expected outcomes based on your disease type, stage, and transplant approach. Recovery milestones include neutrophil engraftment, platelet recovery, hospital discharge, and incremental immune reconstitution over months. Disease status is monitored through blood tests and bone marrow biopsies at defined intervals.

A bone marrow transplant in Thailand typically costs between $30,000 and $54,000. Autologous transplants sit at the lower end of the range, while allogeneic and haploidentical procedures cost more due to donor workup, longer isolation stays, GVHD management, and additional supportive care.

The haematologist's fee covers pre-transplant assessment, conditioning oversight, and post-transplant management. Hospital charges include the isolation ward, 24-hour nursing, and blood banking. Conditioning chemotherapy, stem cell processing, and supportive medications are itemised separately. Coordinator support is included throughout.

Transplant type is the main cost driver; autologous is simpler and shorter than allogeneic. Conditioning intensity affects toxicity management costs. Length of isolation stay, transfusion requirements, and complication management all influence the final total. Donor search fees for unrelated registry donors are additional.

Typical ranges at our partner hospitals:

• Autologous transplant: $30,000–$38,000 using own stem cells, with shorter isolation and no GVHD risk
• Matched allogeneic transplant: $40,000–$48,000 with a sibling or registry donor and a longer stay
• Haploidentical transplant: $45,000–$54,000 with a half-matched donor and PTCy protocol

Final pricing is confirmed after pre-transplant evaluation and treatment planning.

Bone marrow transplant in Thailand costs 50 to 70 percent less than equivalent procedures in the US ($90,000–$180,000), Australia (A$75,000–A$150,000), and UK (£66,000–£135,000). For a treatment that can exceed $100,000 privately, the difference makes transplant financially viable for many more patients.

Most patients spend two to four weeks in a HEPA-filtered isolation room while blood counts are at their lowest. Strict hygiene protocols apply and visitors are limited. You transition to a step-down ward once neutrophil counts reach a safe level, though infection precautions continue.

Most patients are cleared to travel six to ten weeks after the transplant infusion, once engraftment is confirmed, immediate complications are resolved, and outpatient monitoring is stable. Your haematologist provides a fitness-to-travel assessment and detailed handover to your home medical team.

Full immune reconstitution takes several months after an autologous transplant and one to two years after an allogeneic transplant.³ During this period you should avoid crowds, raw foods, and contact with unwell people. Vaccinations are readministered on a schedule. Your haematologist monitors for late effects including chronic GVHD, endocrine changes, and secondary malignancy risk.

The transplant itself does not require anaesthesia. The stem cells are given through a drip, much like a blood transfusion, while you are awake and comfortable, with the transplant team monitoring you closely throughout in case of an infusion reaction. There is nothing to feel during this part beyond the line already in place.

What does usually involve sedation is the placement of the central venous line used to deliver conditioning chemotherapy, blood products, and the stem cells themselves. This is a minor procedure carried out under local anaesthetic, often with light sedation so you are relaxed and pain-free, with an anaesthetist or proceduralist present to monitor you. A bone marrow biopsy, where one is needed, is likewise done under local anaesthetic. Your team decides on sedation case by case, taking your blood counts and general condition into account.

Because the whole pathway is demanding, you go through a thorough pre-transplant assessment before any of it begins, including cardiac, pulmonary, hepatic, and renal function tests and infection screening, to confirm you are fit for conditioning. The harder part of the journey is not pain from a procedure but the side effects of high-dose chemotherapy and the engraftment weeks that follow. Your team manages nausea, mouth soreness, and fatigue actively with medication and supportive care, so you are kept as comfortable as the treatment allows at every stage.

Yes. Our partner hospitals hold JCI accreditation and operate dedicated transplant units with the infrastructure these procedures require: HEPA-filtered isolation, 24-hour haematology coverage, blood banking, and intensive care capability. Transplant outcomes at these centres are consistent with published international data.

GVHD prevention begins with donor matching and conditioning protocol selection. Post-transplant immunosuppression, including calcineurin inhibitors and, for haploidentical cases, cyclophosphamide, reduces incidence. When GVHD occurs, it is graded and treated with corticosteroids, additional immunosuppression, or targeted therapies as needed.

Primary graft failure, where donor cells do not engraft, occurs in a small percentage of cases and may require a second transplant or alternative treatment. Disease relapse after transplant is managed through donor lymphocyte infusions, immunotherapy, or other salvage approaches. Your haematologist plans for these contingencies from the outset.

Plan for six to ten weeks minimum. This covers pre-transplant evaluation, conditioning therapy, the transplant infusion, isolation during engraftment, step-down ward recovery, and initial outpatient follow-up before you are cleared to travel home. Some patients require longer stays depending on complications.

Your package covers the haematologist and transplant team, conditioning chemotherapy, stem cell infusion, isolation ward and nursing, pre-transplant diagnostics including HLA typing, post-transplant medications and blood products, and coordinator support. Donor search fees, accommodation, and flights are arranged separately.

We strongly encourage patients to bring a family member or companion for the duration of the stay. The emotional and practical support during isolation and recovery is invaluable. Your coordinator can help arrange nearby accommodation for your companion and facilitate hospital visiting within infection-control guidelines.